Biomarkers in Irritable Bowel Syndrome: Rationale and Practical Use

By afschroeder • January 26, 2026

Guan M, Chang L. Biomarkers in Irritable Bowel Syndrome: Rationale and Practical Use. Gastroenterol Clin North Am. 2026 Mar;55(1):91-105. doi: 10.1016/j.gtc.2025.08.002. Epub 2025 Oct 21. PMID: 41581955.

Tags: Biomarker, Digestive Diseases, DNA methylation, General Internal Medicine, Irritable Bowel Syndrome, microbiome, Publications, Resident, Short chain fatty acids, Volatile organic compounds

The Current Landscape of Microbial Biomarkers in Gastrointestinal Disease

Kim SG, Zhao MY, Lam C, Jacobs JP. The Current Landscape of Microbial Biomarkers in Gastrointestinal Disease. Gastroenterol Clin North Am. 2026 Mar;55(1):165-184. doi: 10.1016/j.gtc.2025.10.003.[...]

Are Urologists and/or Radiation Oncologists Biased when Reporting of Advantages and Disadvantages of Surgery versus Radiation in Consultations for Early-Stage Prostate Cancer?

Friedrich NA, Luu M, Gale R, Chaplin A, Polineni R, Shiang A, Shin D, Freedland SJ, Spiegel B, Ballas LK, Kokorowski P, Daskivich TJ. Are[...]

Translated Educational Infographics Increase Colorectal Cancer Screening Rates in Non-Native English Speakers

Zhornitskiy A, Nguyen BS, Shieh C, Nasirishargh A, Valenti L, Perez JLM, Zhornitsky F, Do T, Nguyen JT, Jeong S, Hsu R. Translated Educational Infographics[...]